BSBarbara Kellerman Smith

Barbara Kellerman Smith

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Barbara Kellerman Smith has a total of 169 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inspiratory Muscle Training Before Total Joint Arthroplasty to Improve Postoperative Outcomes: Protocol for a Randomized Controlled Trial

    by Barbara K Smith, Julie Shaner, Adam Gitlin, William Meier, Sabrina Wang, Maribel Ciampitti, Tatiana Elias-Grajeda, Ushna Khan, Johnny Washington, Michael Freidl, et al.

    Background: Total joint arthroplasty (TJA) is among the most common elective surgeries performed in the United States, and recent advances in perioperative care have shortened hospital stays and streamlined recovery. Yet, even brief periods of mechanical ventilation and anesthesia measurably weaken respiratory muscle function in the early postoperative period. Preoperative inspiratory strength training (IST) has been shown to reduce postoperative pulmonary complications in patients undergoing major cardiothoracic surgery, but whether these benefits extend to shorter procedures such as TJA, where hospital stays are already brief, remains unknown. Objective: This study aims to investigate whether preoperative IST prior to TJA surgery alters respiratory strength, lung function, and functional mobility. We hypothesize that preoperative IST is feasible and effective in increasing inspiratory strength and promoting the return of early postoperative respiratory function and functional mobility before hospital discharge. Methods: The study hypothesis will be tested using a randomized, prospective design at a single urban academic health system. Adults scheduled for TJA surgery will be randomized to either undergo daily IST (dIST), complete an acute IST (aIST) session in the preoperative area, or receive clinical standard of care (SOC). Inspiratory muscle strength and pulmonary function will be evaluated upon enrollment at a baseline assessment approximately 4 weeks before surgery and will be repeated on the day of surgery. Postoperative changes will be evaluated through the first 24 hours across 3 aims: to evaluate the feasibility and effectiveness of dIST for increasing preoperative respiratory strength (aim 1), to compare the effects of dIST and aIST on postoperative respiratory strength measures and lung function (aim 2), and to evaluate 24-hour functional outcomes (aim 3). Results: The study was funded in September 2023 and received institutional review board and safety officer approvals in December 2023. Enrollment began in March 2024, and as of May 2026, a total of 31 participants have been enrolled. Data analysis and publication of primary results are expected in 2027. Conclusions: This trial will provide the first controlled investigation of preoperative IST in TJA, offering early evidence on whether a low-cost, nonpharmacological intervention can preserve respiratory strength and accelerate functional recovery in this high-volume surgical population.

  • Open Access

    Inspiratory Muscle Training to Improve Total Joint Arthroplasty Outcomes: Trial Protocol (Preprint)

    by Barbara K. Smith, Julie Shaner, Adam Gitlin, William Meier, Sabrina Wang, Maribel Ciampitti, Tatiana Elijas-Grajeda, Ushna Khan, Johnny Washington, Michael Freidl, et al.

    UNSTRUCTURED Total joint arthroplasty (TJA) surgeries are common elective surgeries in the US, and recent care optimization practices have enhanced preoperative readiness. Despite improvements in the efficiency of pre- and post-operative TJA care, even short periods of mechanical ventilation and anesthesia reduce early postoperative lung and respiratory muscle function. In patients undergoing other major surgeries, preoperative inspiratory strength training (IST) reduces the occurrence of post-operative pulmonary complications (PPC’s), but the potential benefits of preoperative IST have not been systematically investigated in shorter surgeries such as TJA with expected brief hospital length of stay. We intend to address this gap in understanding by investigating whether preoperative IST prior to TJA surgery alters respiratory strength, lung function, and functional mobility. The primary study hypothesis is that preoperative IST is feasible and effective to increase inspiratory strength and promote the return of early post-operative respiratory function and functional mobility, in advance of hospital discharge. The study hypothesis will be tested with a randomized, prospective study at a single urban academic health system. Adults scheduled for TJA surgery will be randomized to either undergo daily preoperative IST (dIST), complete an acute IST session in the preoperative area (aIST), or receive clinical standard of care (SOC). Inspiratory muscle strength and pulmonary function will be evaluated upon enrollment at a baseline assessment ~4 weeks in advance of surgery and repeated on the day of surgery. Post-operative changes will be evaluated through the first 24 hours. The study design will establish feasibility and effectiveness of dIST to increase preoperative respiratory strength (Aim 1). We will also compare effects of dIST versus aIST on important post-operative respiratory strength measures and lung function (Aim 2) and 24-hour functional outcomes (Aim 3). This investigation will provide the first controlled study of preoperative IST to optimize respiratory recovery following TJA.

  • Open Access

    Acute Adenosine Receptor Antagonism in Combination With Acute Intermittent Hypoxia to Promote Breathing Plasticity in Amyotrophic Lateral Sclerosis: Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial

    by Priscila Sales de Campos, May Smith-Hublou, Wendy L Olsen, Wagner Souza Leite, James P Wymer, Nicholas J Napoli, Alicia K Vose, Michael T Pulley, Gordon S Mitchell, Barbara K Smith

    Background: Respiratory impairment is a major concern in amyotrophic lateral sclerosis (ALS), shortening survival and lowering quality of life. One therapy with promise to delay respiratory decline in ALS is acute intermittent hypoxia (AIH), consisting of alternating periods of breathing mildly hypoxic (9%-12% O2) and normoxic (21% O2) gas. AIH stimulates spinal, serotonin-dependent neuroplasticity in rodent models, conferring functional benefits in diverse physiological systems without detectable pathology. However, in rodent models, AIH-induced neuroplasticity is constrained by distinct signaling cascades initiated by spinal adenosine. Objective: We propose to investigate a therapeutic strategy to delay breathing compromise in those living with ALS by combining a selective adenosine 2A (A2A) receptor inhibitor (istradefylline) with AIH. The fundamental hypothesis guiding this proposal is that a single AIH trial after pretreatment with istradefylline enhances respiratory neuroplasticity versus AIH or sham intervention. Methods: We propose to evaluate resting breathing, respiratory strength, and participant-reported symptoms in adults living with ALS after combined istradefylline plus AIH. A mixed within- and between-participant study design incorporates 4 test sessions, separated by approximately 2 weeks (±5 days). Testing conditions include single sessions of AIH + istradefylline, AIH + placebo, sham AIH (ie, normoxia) + placebo, and sham AIH + istradefylline. Safety and feasibility will be characterized using the rate of adverse events, changes in vital signs, and participant-reported breathing sensations (Aim 1). Neuroplasticity of breathing and motor function will be evaluated as changes in resting breathing, voluntary respiratory strength, respiratory control, and maximal pinch force (Aim 2). Results: As of January 2025, with a target sample of 16 participants in each group, 10 participants with ALS and 5 control participants completed study procedures. Recruiting is ongoing, and the final participant will complete the study by December 2025. Publication of results is expected by the end of 2026. Conclusions: These aims will provide crucial data regarding the preliminary safety and feasibility of this paired intervention and help optimize therapeutic AIH as a rehabilitation strategy, thereby guiding further research concerning this novel treatment for ALS. Trial Registration: ClinicalTrials.gov NCT05377424; https://clinicaltrials.gov/study/NCT05377424 International Registered Report Identifier (IRRID): DERR1-10.2196/76105


  • Open Access

    Leveraging intrinsic non-sinusoidal patterns to infer search behavior to predict exposure to respiratory stressors

    by Anju Bimal, Szilard L. Beres, Victoria Ribeiro Rodrigues, Barbara K. Smith, Paul W. Davenport, Nicholas J. Napoli

    Entropy-based metrics analyzing respiratory phase transitions (inspiration-to-expiration and expiration-to-inspiration) detect respiratory compromise under hypoxic conditions better than standard breathing rate measurements. Analysis of nonlinear dynamics during these transitions reveals key ventilatory adaptations during exposure to respiratory stressors. Measuring timing variations at phase transitions improves predictive model performance in detecting exposure to hypoxic environments by a 50.76% increase in area under the curve (AUC) vs. classical methods.


  • Open Access

    Acute Adenosine Receptor Antagonism in Combination With Acute Intermittent Hypoxia to Promote Breathing Plasticity in Amyotrophic Lateral Sclerosis: Protocol for a Randomized, Double-Blinded, Placebo-Controlled Trial (Preprint)

    by Priscila Sales de Campos, May Smith-Hublou, Wendy L Olsen, Wagner Souza Leite, James P Wymer, Nicholas J Napoli, Alicia K Vose, Michael T Pulley, Gordon S Mitchell, Barbara K Smith

    BACKGROUND Respiratory impairment is a major concern in amyotrophic lateral sclerosis (ALS), shortening survival and lowering quality of life. One therapy with promise to delay respiratory decline in ALS is acute intermittent hypoxia (AIH), consisting of alternating periods of breathing mildly hypoxic (9%-12% O2) and normoxic (21% O2) gas. AIH stimulates spinal, serotonin-dependent neuroplasticity in rodent models, conferring functional benefits in diverse physiological systems without detectable pathology. However, in rodent models, AIH-induced neuroplasticity is constrained by distinct signaling cascades initiated by spinal adenosine. OBJECTIVE We propose to investigate a therapeutic strategy to delay breathing compromise in those living with ALS by combining a selective adenosine 2A (A2A) receptor inhibitor (istradefylline) with AIH. The fundamental hypothesis guiding this proposal is that a single AIH trial after pretreatment with istradefylline enhances respiratory neuroplasticity versus AIH or sham intervention. METHODS We propose to evaluate resting breathing, respiratory strength, and participant-reported symptoms in adults living with ALS after combined istradefylline plus AIH. A mixed within- and between-participant study design incorporates 4 test sessions, separated by approximately 2 weeks (±5 days). Testing conditions include single sessions of AIH + istradefylline, AIH + placebo, sham AIH (ie, normoxia) + placebo, and sham AIH + istradefylline. Safety and feasibility will be characterized using the rate of adverse events, changes in vital signs, and participant-reported breathing sensations (Aim 1). Neuroplasticity of breathing and motor function will be evaluated as changes in resting breathing, voluntary respiratory strength, respiratory control, and maximal pinch force (Aim 2). RESULTS As of January 2025, with a target sample of 16 participants in each group, 10 participants with ALS and 5 control participants completed study procedures. Recruiting is ongoing, and the final participant will complete the study by December 2025. Publication of results is expected by the end of 2026. CONCLUSIONS These aims will provide crucial data regarding the preliminary safety and feasibility of this paired intervention and help optimize therapeutic AIH as a rehabilitation strategy, thereby guiding further research concerning this novel treatment for ALS. CLINICALTRIAL ClinicalTrials.gov NCT05377424; https://clinicaltrials.gov/study/NCT05377424 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/76105

  • Open Access

    Respiratory Strength Training Versus Respiratory Relaxation Training in the Rehabilitation of Physical Impairment, Function, and Return to Participation After Stroke: Protocol for a Randomized Controlled Trial

    by Dorian K Rose, Gina Brunetti, Kathryn Cavka, J Brooke Hoisington, Hannah Snyder, Wei Xue, Barbara K Smith

    Background: Persistent disability in chronic stroke survivors is often attributed to arm or leg weakness; however, respiratory muscle weakness also impedes poststroke rehabilitation, reduces quality of life, and increases the risk of health complications. Respiratory complications are common after stroke and place patients at risk for both prolonged functional disability and mortality. In addition, stroke survivors face ongoing cardiovascular disease that places them at risk for recurrent stroke. Objective: The study aims to compare the effects of 2 respiratory training programs, paired with individualized flexibility, strengthening, and cardiovascular exercise programs, on physiologic, activity, and societal participation outcomes in chronic stroke survivors. Methods: This study will be a randomized controlled trial. Participants are 80 community-dwelling adults with chronic stroke. In conjunction with a 24-session (3 times/week for 8 weeks), American Heart Association–informed, whole-body exercise program, participants will be randomized to receive either respiratory strength training or respiratory relaxation training. Study intervention will be directed by a physical therapist and take place in a community fitness center. Outcome assessments will occur in a clinical research center. The primary outcome measure is maximal respiratory pressure. Secondary outcome measures include airway clearance, walking endurance, spatial-temporal gait characteristics, community walking, functional strength and fatigue, depression, and societal participation measures. Longer-term societal participation is a complex domain that may be influenced by other factors beyond physical function. Participants’ health status will be monitored for 1 year following the intervention for falls, respiratory illness, and hospitalizations. Additional subanalyses will evaluate the effect of smoke exposure on short- and long-term outcomes. Outcome assessors are blinded to group assignments. Respiratory relaxation training is an active comparator, but no pure control group is included. Results: This study was funded in March 2020 with enrollment commencing in November 2020. Completion of enrollment is projected for May 2025 with a study projected end date of April 2026. Published results are anticipated in Fall 2026. Conclusions: Results from this study will improve our understanding of the additive benefits of respiratory exercises on short- and long-term physiologic, functional, and societal gains for these individuals. These data will be instructive to meet a current unmet rehabilitative need to promote patient-centered care and contribute to decreasing morbidity and mortality in chronic stroke survivors. Trial Registration: ClinicalTrials.gov: NCT05819333; https://clinicaltrials.gov/study/NCT05819333 International Registered Report Identifier (IRRID): DERR1-10.2196/59749


  • Open Access

    Home-Based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors: Protocol of the HEAL Sepsis Randomized Clinical Trial

    by Rola S Zeidan, Margaret K Ohama, Natalia Evripidou, Stephen D Anton, Laith L Hamed, Yi Lin, Christiaan Leeuwenburgh, Faheem W Guirguis, Philip A Efron, Sheryl Flynn, et al.

    Background: While sepsis, an exaggerated response to infection, can affect people of all age groups, it is more prevalent in middle-aged and older adults. Older adults suffer worse short-term and long-term outcomes than younger patients. Older sepsis survivors are commonly discharged to long-term acute care facilities, where they often die within 1 year. Those who return home from the hospital lose the momentum of physical function improvement after early inpatient rehabilitation, and often face exacerbation of comorbidities and decline in physical function. Additionally, patients who are discharged home often live at distant locations and are not able to commute to rehabilitation centers due to their poor health status. Therefore, remotely delivered exercise interventions tailored to this population hold promise to improve physical function safely and effectively after sepsis. However, this type of intervention has yet to be tested in this population. Objective: This study aims to assess the safety, feasibility, and ease of recruitment and retention of participants for a remotely delivered physical activity intervention for improving physical function in middle-aged and older sepsis survivors. Methods: The proposed intervention will be delivered through a digital health platform that comprises a patient-facing mobile app and a 12-week physical activity program specifically designed for middle-aged and older sepsis survivors with poor health status who may face challenges participating in traditional out-patient or community-based exercise interventions. This study is ongoing and plans to enroll 40 sepsis survivors aged 55 years and older who will be randomized to either a remotely delivered exercise intervention group or a control group (electronic health diary). Both groups will use a tablet containing the Health in Motion app (Blue Marble Health). The intervention group will receive a clinician-designed personalized avatar-guided home exercise program and reminders while the control group will self-report daily activities using the in-app health diary feature. Results: This study is the first to use a home-based, remotely monitored 12-week exercise program to improve physical function in sepsis survivors. This study will evaluate the safety, feasibility, and efficacy, providing the necessary knowledge to design and calculate power for future larger trials. Conclusions: This study will provide important information for planning a future randomized clinical trial to test the efficacy of a remotely delivered exercise intervention in this high-risk population. Trial Registration: ClinicalTrials.gov NCT05568511; https://clinicaltrials.gov/study/NCT05568511 International Registered Report Identifier (IRRID): DERR1-10.2196/60270


  • Open Access

    Home-Based Digital Exercise Training Program to Improve Physical Function of Older Sepsis Survivors: Protocol of the HEAL Sepsis Randomized Clinical Trial (Preprint)

    by Rola S Zeidan, Margaret K Ohama, Natalia Evripidou, Stephen D Anton, Laith L Hamed, Yi Lin, Christiaan Leeuwenburgh, Faheem W Guirguis, Philip A Efron, Sheryl Flynn, et al.

    BACKGROUND While sepsis, an exaggerated response to infection, can affect people of all age groups, it is more prevalent in middle-aged and older adults. Older adults suffer worse short-term and long-term outcomes than younger patients. Older sepsis survivors are commonly discharged to long-term acute care facilities, where they often die within 1 year. Those who return home from the hospital lose the momentum of physical function improvement after early inpatient rehabilitation, and often face exacerbation of comorbidities and decline in physical function. Additionally, patients who are discharged home often live at distant locations and are not able to commute to rehabilitation centers due to their poor health status. Therefore, remotely delivered exercise interventions tailored to this population hold promise to improve physical function safely and effectively after sepsis. However, this type of intervention has yet to be tested in this population. OBJECTIVE This study aims to assess the safety, feasibility, and ease of recruitment and retention of participants for a remotely delivered physical activity intervention for improving physical function in middle-aged and older sepsis survivors. METHODS The proposed intervention will be delivered through a digital health platform that comprises a patient-facing mobile app and a 12-week physical activity program specifically designed for middle-aged and older sepsis survivors with poor health status who may face challenges participating in traditional out-patient or community-based exercise interventions. This study is ongoing and plans to enroll 40 sepsis survivors aged 55 years and older who will be randomized to either a remotely delivered exercise intervention group or a control group (electronic health diary). Both groups will use a tablet containing the Health in Motion app (Blue Marble Health). The intervention group will receive a clinician-designed personalized avatar-guided home exercise program and reminders while the control group will self-report daily activities using the in-app health diary feature. RESULTS This study is the first to use a home-based, remotely monitored 12-week exercise program to improve physical function in sepsis survivors. This study will evaluate the safety, feasibility, and efficacy, providing the necessary knowledge to design and calculate power for future larger trials. CONCLUSIONS This study will provide important information for planning a future randomized clinical trial to test the efficacy of a remotely delivered exercise intervention in this high-risk population. CLINICALTRIAL ClinicalTrials.gov NCT05568511; https://clinicaltrials.gov/study/NCT05568511 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/60270

  • Open Access

    Respiratory Strength Training Versus Respiratory Relaxation Training in the Rehabilitation of Physical Impairment, Function, and Return to Participation After Stroke: Protocol for a Randomized Controlled Trial (Preprint)

    by Dorian K Rose, Gina Brunetti, Kathryn Cavka, J Brooke Hoisington, Hannah Snyder, Wei Xue, Barbara K Smith

    BACKGROUND Persistent disability in chronic stroke survivors is often attributed to arm or leg weakness; however, respiratory muscle weakness also impedes poststroke rehabilitation, reduces quality of life, and increases the risk of health complications. Respiratory complications are common after stroke and place patients at risk for both prolonged functional disability and mortality. In addition, stroke survivors face ongoing cardiovascular disease that places them at risk for recurrent stroke. OBJECTIVE The study aims to compare the effects of 2 respiratory training programs, paired with individualized flexibility, strengthening, and cardiovascular exercise programs, on physiologic, activity, and societal participation outcomes in chronic stroke survivors. METHODS This study will be a randomized controlled trial. Participants are 80 community-dwelling adults with chronic stroke. In conjunction with a 24-session (3 times/week for 8 weeks), American Heart Association–informed, whole-body exercise program, participants will be randomized to receive either respiratory strength training or respiratory relaxation training. Study intervention will be directed by a physical therapist and take place in a community fitness center. Outcome assessments will occur in a clinical research center. The primary outcome measure is maximal respiratory pressure. Secondary outcome measures include airway clearance, walking endurance, spatial-temporal gait characteristics, community walking, functional strength and fatigue, depression, and societal participation measures. Longer-term societal participation is a complex domain that may be influenced by other factors beyond physical function. Participants’ health status will be monitored for 1 year following the intervention for falls, respiratory illness, and hospitalizations. Additional subanalyses will evaluate the effect of smoke exposure on short- and long-term outcomes. Outcome assessors are blinded to group assignments. Respiratory relaxation training is an active comparator, but no pure control group is included. RESULTS This study was funded in March 2020 with enrollment commencing in November 2020. Completion of enrollment is projected for May 2025 with a study projected end date of April 2026. Published results are anticipated in Fall 2026. CONCLUSIONS Results from this study will improve our understanding of the additive benefits of respiratory exercises on short- and long-term physiologic, functional, and societal gains for these individuals. These data will be instructive to meet a current unmet rehabilitative need to promote patient-centered care and contribute to decreasing morbidity and mortality in chronic stroke survivors. CLINICALTRIAL ClinicalTrials.gov: NCT05819333; https://clinicaltrials.gov/study/NCT05819333 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/59749

  • Longitudinal changes of swallowing safety and efficiency in infants with spinal muscular atrophy who received disease modifying therapies

    by Carmen Leon‐Astudillo, Olivia Brooks, Stephanie M. Salabarria, Mackenzi Coker, Manuela Corti, Jenna Lammers, Emily K. Plowman, Barry J. Byrne, Barbara K. Smith

    Background: Dysphagia is a common feature of the natural history of patients with spinal muscular atrophy (SMA). Literature regarding swallowing safety and efficiency is scarce in patients with SMA, particularly in the era of newborn screening programs and disease‐modifying therapies.Objective: To describe the longitudinal changes of swallowing safety and efficiency in children with SMA who received one or more disease modifying therapiesMethods: Case series of patients with SMA followed at the University of Florida from 1 May 2019 to 31 December 2022 who had two or more videofluoroscopy swallowing studies (VFSS), with the first being within 30 days of their first treatment. Data extracted from the electronic health record included: neuromotor outcomes, VFSS penetration aspiration scores (PAS), presence of abrnormal oral or pharyngeal residue, clinical history, and timing of disease‐modifying therapies administration.Results: Seven subjects were included (five male); three were diagnosed via newborn screen. Median age at diagnosis was 10 days (range: 4–250). Median age at initial VFSS was 29 days (range: 9–246), and age at the last VFSS was 26.1 months (range: 18.2–36.2). All subjects received onasemnogene‐abeparvovec (OA); four received additional therapies. PAS at diagnosis was abnormal in four subjects. Six subjects required feeding modifications after VFSS results. Of these, three had silent aspiration (PAS 8) and three of them improved after treatment.Conclusions: Swallowing safety and efficiency can be impaired in patients with SMA despite early treatment. Larger, prospective studies are needed to define optimal timiing of longitudinal instrumental evaluations.